Monday Educational Symposiums during the ISPOR 3rd Asia-Pacific Conference

Presented in English with simultaneous Korean translation

MONDAY, 8 SEPTEMBER 2008 1:00PM-2:00PM

The Use of Economic Models in Diabetes

1.00PM – 1.10PM     ESTIMATING EFFECTIVENESS: MODELLING VERSUS REAL-WORLD STUDIES
Manny Papadimitropoulos PhD, Director, Outcomes Research Intercontinental Region & Japan, Eli Lilly & Company, and Assistant Professor, University of Toronto, Faculty of Pharmacy, Social & Administrative Pharmacy, Toronto, ON, Canada
                              
1.10PM – 1.35PM     USE OF MODELING IN DIABETES
Doug Coyle MA, MSc, PhD, Associate Professor, University of Ottawa, Faculty of Medicine Epidemiology & Community Medicine, Ottawa, ON, Canada

1.35PM – 1.45PM     REAL-WORLD DATA                      
Diana Brixner PhD, 2007-2008 ISPOR President and Associate Professor and Department Chair, College of Pharmacy, University of Utah, College of Pharmacy, Salt Lake City, UT, USA

1.45PM – 2.00PM     QUESTION & ANSWER/DISCUSSION

Sponsored by Eli Lilly

Monday Educational Symposiums during the ISPOR 3rd Asia-Pacific Conference

MONDAY, 8 SEPTEMBER 2008 7:00PM-8:00PM

VALUE OF ANTIVIRAL TREATMENTS FOR CHRONIC HEPATITIS B

Due to its high prevalence rate, chronic hepatitis B (CHB) is a public health concern in most countries of the Asia Pacific region. New antiviral treatments have emerged for CHB with different clinical profiles and drug acquisition costs. These new treatments have created issues relating to how to evaluate the value of different antivirals for CHB. This symposium aims to address these issues through review and discussion of current literature on the topic.

7:00PM–7:05PM Welcome and Introduction
Moderator: Bong-Min Yang PhD, Professor of Economics, School of Public Health, Seoul National University,
Seoul, South Korea

7:05PM–7:20PM Who to Treat? – Identifying Those at Greatest Risk
Speaker: Chien-Jen Chen MPH, ScD, Academician & Distinguished Research fellow, Genomics Research Center, Academia Sinica, Taipei, Taiwan

7:20PM-7:35PM Clinical framework for considering the Value of Treatment in CHB
Speaker: Henry Chan MBChB, MD, Professor of Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong

7:35PM-7:50PM Economic framework for considering the Value of Treatment in CHB
Speaker: Lim Seng Gee MBBS, MD, Chief Department of Gastroenterology & Hepatology, Department of Medicine, National University Hospital, National University of Singapore, Singapore

7:50PM-8:00PM Panel Discussion
Moderator: Bong-Min Yang PhD, Professor of Economics, School of Public Health, Seoul National University,
Seoul, South Korea

Sponsored by Bristol-Myers Squibb